nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—ADRB3—Amine ligand-binding receptors—HRH3—narcolepsy	0.0381	0.0381	CbGpPWpGaD
Labetalol—ADRB3—G alpha (s) signalling events—P2RY11—narcolepsy	0.0278	0.0278	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0226	0.0226	CbGpPWpGaD
Labetalol—ADRB3—Monoamine GPCRs—HTR2A—narcolepsy	0.0226	0.0226	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0221	0.0221	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Other—P2RY11—narcolepsy	0.0207	0.0207	CbGpPWpGaD
Labetalol—ADRB3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.019	0.019	CbGpPWpGaD
Labetalol—ADRB1—G alpha (s) signalling events—P2RY11—narcolepsy	0.0165	0.0165	CbGpPWpGaD
Labetalol—ADRB2—G alpha (s) signalling events—P2RY11—narcolepsy	0.0162	0.0162	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.016	0.016	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.016	0.016	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0155	0.0155	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Labetalol—ADRB1—Monoamine GPCRs—HTR2A—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0133	0.0133	CbGpPWpGaD
Labetalol—ADRB2—Monoamine GPCRs—HTR2A—narcolepsy	0.0131	0.0131	CbGpPWpGaD
Labetalol—ADRB3—G alpha (s) signalling events—NPS—narcolepsy	0.013	0.013	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Labetalol—ADRB1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Labetalol—ADRB2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.011	0.011	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—HCRTR2—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—HCRTR1—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—P2RY11—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00952	0.00952	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00952	0.00952	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00932	0.00932	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00932	0.00932	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0092	0.0092	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.009	0.009	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00876	0.00876	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—HCRT—narcolepsy	0.0086	0.0086	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00855	0.00855	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00798	0.00798	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00798	0.00798	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00788	0.00788	CbGpPWpGaD
Labetalol—ADRB1—G alpha (s) signalling events—NPS—narcolepsy	0.00774	0.00774	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00771	0.00771	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—PENK—narcolepsy	0.00766	0.00766	CbGpPWpGaD
Labetalol—ADRB2—G alpha (s) signalling events—NPS—narcolepsy	0.00757	0.00757	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0075	0.0075	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0067	0.0067	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00655	0.00655	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—TRH—narcolepsy	0.00651	0.00651	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00622	0.00622	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00622	0.00622	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HCRTR2—narcolepsy	0.00621	0.00621	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HCRTR1—narcolepsy	0.00621	0.00621	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HCRTR2—narcolepsy	0.00608	0.00608	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HCRTR1—narcolepsy	0.00608	0.00608	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—P2RY11—narcolepsy	0.006	0.006	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00597	0.00597	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00592	0.00592	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00592	0.00592	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—P2RY11—narcolepsy	0.00587	0.00587	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00584	0.00584	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Other—HTR2A—narcolepsy	0.00583	0.00583	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—P2RY11—narcolepsy	0.00571	0.00571	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—HRH3—narcolepsy	0.00571	0.00571	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HCRTR2—narcolepsy	0.00537	0.00537	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HCRTR1—narcolepsy	0.00537	0.00537	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0052	0.0052	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—P2RY11—narcolepsy	0.00519	0.00519	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HCRT—narcolepsy	0.0051	0.0051	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00508	0.00508	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00508	0.00508	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.00499	0.00499	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00497	0.00497	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HCRT—narcolepsy	0.00486	0.00486	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—NPS—narcolepsy	0.00473	0.00473	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—TAC1—narcolepsy	0.00473	0.00473	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—PENK—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HCRT—narcolepsy	0.00441	0.00441	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00436	0.00436	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00436	0.00436	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PENK—narcolepsy	0.00433	0.00433	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PENK—narcolepsy	0.00393	0.00393	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—TRH—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.00378	0.00378	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00374	0.00374	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—TRH—narcolepsy	0.00368	0.00368	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00361	0.00361	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00361	0.00361	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00351	0.00351	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00351	0.00351	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—P2RY11—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HRH3—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—TRH—narcolepsy	0.00334	0.00334	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.00332	0.00332	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.00332	0.00332	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HRH3—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HCRTR1—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HCRTR2—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HCRTR1—narcolepsy	0.00317	0.00317	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HCRTR2—narcolepsy	0.00317	0.00317	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.00312	0.00312	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.00312	0.00312	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—P2RY11—narcolepsy	0.00308	0.00308	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—P2RY11—narcolepsy	0.00306	0.00306	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.00301	0.00301	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HRH3—narcolepsy	0.00293	0.00293	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HCRT—narcolepsy	0.00288	0.00288	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—HTR2A—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.00282	0.00282	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—NPS—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—TAC1—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—TAC1—narcolepsy	0.00267	0.00267	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—NPS—narcolepsy	0.00267	0.00267	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HCRT—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HCRT—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PENK—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.00256	0.00256	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—TAC1—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—NPS—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PENK—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PENK—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—TRH—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—TRH—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TRH—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—TRH—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HRH3—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HCRTR1—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HCRTR2—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—P2RY11—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—P2RY11—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HRH3—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HRH3—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HRH3—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—HTR2A—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—HTR2A—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—TAC1—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—NPS—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—NPS—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HCRT—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HCRT—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HTR2A—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—NPS—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—TAC1—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TAC1—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NPS—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—NPS—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—TAC1—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PENK—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PENK—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CHKB—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TRH—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TRH—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HRH3—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HRH3—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR2A—narcolepsy	0.000955	0.000955	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	0.000934	0.000934	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR2A—narcolepsy	0.000867	0.000867	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR2A—narcolepsy	0.000863	0.000863	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NPS—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TAC1—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	0.000848	0.000848	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NPS—narcolepsy	0.000833	0.000833	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TAC1—narcolepsy	0.000833	0.000833	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR2A—narcolepsy	0.000512	0.000512	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR2A—narcolepsy	0.000501	0.000501	CbGpPWpGaD
